We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

28 hedge funds and large institutions have $5.77M invested in Assembly Biosciences in 2014 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 4 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

125% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 4

18% less funds holding

Funds holding: 34 → 28 (-6)

30% less call options, than puts

Call options by funds: $21K | Put options by funds: $30K

46% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 13

84% less capital invested

Capital invested by funds: $37.2M → $5.77M (-$31.5M)

Holders
28
Holders Change
-6
Holders Change %
-17.65%
% of All Funds
0.81%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
9
Reduced
4
Closed
13
Calls
$21K
Puts
$30K
Net Calls
-$9K
Net Calls Change
-$109K

Top Buyers

Rank Fund Capital Flow
1
BIT
BlackRock Institutional Trust
California
+$1.2M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$312K
3
Goldman Sachs
Goldman Sachs
New York
+$275K
4
Citadel Advisors
Citadel Advisors
Florida
+$234K
5
Group One Trading
Group One Trading
Illinois
+$126K

Top Sellers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
-$7.07M
2
EM
Elliott Management
New York
-$6.81M
3
TAM
THB Asset Management
Connecticut
-$3.89M
4
BBA
Baker Bros. Advisors
New York
-$2.07M
5
TC
TFS Capital
Pennsylvania
-$828K
Name Holding Trade Value Shares
Change 		Change in
Stake
VAM
1
Visium Asset Management
New York
$2.3M – – –
BIT
2
BlackRock Institutional Trust
California
$1.27M +$1.2M +7,679 +87%
BBA
3
Baker Bros. Advisors
New York
$535K -$2.07M -13,302 -66%
Vanguard Group
4
Vanguard Group
Pennsylvania
$510K +$312K +2,003 +43%
Renaissance Technologies
5
Renaissance Technologies
New York
$174K +$71.7K +460 +25%
Goldman Sachs
6
Goldman Sachs
New York
$135K +$275K +1,764 New
Citadel Advisors
7
Citadel Advisors
Florida
$115K +$234K +1,503 New
Deutsche Bank
8
Deutsche Bank
Germany
$109K -$225K -1,444 -50%
BFA
9
BlackRock Fund Advisors
California
$97K +$24K +154 +14%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$97K +$57.6K +370 +41%
California Public Employees Retirement System
11
California Public Employees Retirement System
California
$68K – – –
Group One Trading
12
Group One Trading
Illinois
$62K +$126K +810 New
VKH
13
Virtu KCG Holdings
New York
$60K +$85.5K +549 +224%
Northern Trust
14
Northern Trust
Illinois
$42K – – –
Morgan Stanley
15
Morgan Stanley
New York
$42K +$2.49K +16 +3%
BRWA
16
B. Riley Wealth Advisors
Florida
$30K -$216K -1,384 -78%
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
$30K +$61.4K +394 New
U
18
UBS
Switzerland
$28K +$54.7K +351 +1,755%
Millennium Management
19
Millennium Management
New York
$27K +$55.9K +359 New
Bank of New York Mellon
20
Bank of New York Mellon
New York
$16K – – –
GC
21
Guggenheim Capital
Illinois
$14K +$27.4K +176 New
BA
22
BlackRock Advisors
Delaware
$9K – – –
Citigroup
23
Citigroup
New York
$2K +$3.89K +25 +417%
BNP Paribas Financial Markets
24
BNP Paribas Financial Markets
France
$1.27K – – –
Wells Fargo
25
Wells Fargo
California
$1K -$3.89K -25 -76%
1
2

ASMB Hedge Fund Activity: Q1 2014 in Review

28 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q1 2014, worth a combined $5.77M — down 84% from $37.2M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of ASMB and 7 opened new positions — a net loss of 6 holders — while 4 trimmed existing stakes and 9 added.

The largest buyer was BlackRock Institutional Trust, adding an estimated $1.2M. The largest seller was Broadfin Capital, exiting entirely with an estimated $7.07M sold.

  • 28 institutional investors held Assembly Biosciences (ASMB) as of Q1 2014, down from 34 in Q4 2013.
  • Funds reported $5.77M of Assembly Biosciences stock for Q1 2014, down 84% quarter-over-quarter.
  • 7 funds opened new Assembly Biosciences positions in Q1 2014 and 13 closed out, a net change of -6 holders.
  • The largest Assembly Biosciences buyer in Q1 2014 was BlackRock Institutional Trust, an estimated $1.2M added.
  • The largest Assembly Biosciences seller in Q1 2014 was Broadfin Capital, an estimated $7.07M sold.

Based on aggregated 13F filings for Q1 2014.